ストックスクリーナーアプリを入手
0.00
100.00%
-1.78
アフターアワーズ：
1.76
1.76
+
Trevena Inc (TRVN) 最新ニュース
Trevena Announces Board and Executive ChangesOn January 31, 2025, Trevena, Inc. (NASDAQ:TRVN) filed a Form 8-K with the Securities and Exchange Commission, detailing significant departures and appointments within the company.In line with ongoin - Defense World
Trevena Implements Cost-Cutting Measures Amid Leadership Changes - TipRanks
Trevena (NASDAQ:TRVN) Shares Cross Below 200 Day Moving Average – Time to Sell? - Defense World
StockNews.com Begins Coverage on Trevena (NASDAQ:TRVN) - Defense World
StockNews.com Initiates Coverage on Trevena (NASDAQ:TRVN) - Defense World
Trevena discontinues OLINVYK injection sales By Investing.com - Investing.com Canada
Trevena discontinues OLINVYK injection sales - Investing.com
Trevena (NASDAQ:TRVN) Stock Price Crosses Above Fifty Day Moving Average – What’s Next? - Defense World
Trevena (NASDAQ:TRVN) Coverage Initiated at StockNews.com - Defense World
Trevena Announces FDA Acceptance For Review Of New Drug Application For OLINVO(Oliceridine) Injection - Reuters.com
Trevena (NASDAQ:TRVN) Now Covered by Analysts at StockNews.com - Defense World
Trevena Announces Reverse Stock Split to Regain Nasdaq Compliance - MSN
With a 1.8% CAGR, the Opioid Market is Expected to Reach USD 28.45 billion by 2034 | PMR - GlobeNewswire
Trevena's SWOT analysis: CNS drug developer's stock faces pivotal moment - Investing.com
Trevena's SWOT analysis: stock outlook amid pipeline focus and financial moves - Investing.com Canada
Trevena's SWOT analysis: stock outlook amid pipeline focus and financial moves By Investing.com - Investing.com South Africa
Trevena (TRVN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Compass Therapeutics Appoints Barry Shin as Chief Financial Officer - citybiz
Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer - The Manila Times
Compass Therapeutics Taps Industry Veteran Barry Shin as CFO Ahead of Pivotal Clinical Data - StockTitan
Compass Therapeutics Names Barry Shin Chief Financial Officer - MarketWatch
Trevena appoints new financial chief - Investing.com
Trevena appoints new financial chief By Investing.com - Investing.com Nigeria
Trevena Appoints Katrine Sutton as New CFO - TipRanks
Trevena, Inc. Appoints Katrine Sutton as Principal Financial Officer and Principal Accounting Officer - Marketscreener.com
Trevena, Inc. Navigates Financial Challenges and Strategic Changes - MSN
Post-operative Pain Therapeutics Market Future Prospects, - openPR
ARMISTICE CAPITAL, LLC Acquires New Stake in Trevena Inc - GuruFocus.com
Trevena downgraded to Neutral from Buy at H.C. Wainwright - TipRanks
Trevena Inc. Reports Q3 2024 Financial Results - TipRanks
What to look for when Lowe’s (LOW) reports Q3 2024 earnings results - AlphaStreet
Ultragenyx Q3 Loss Narrower Than Expected, Revenues Beat Estimates - MSN
Postoperative Pain Therapeutics Market Trends, Business Overview, Industry Growth and Forecast to 2031 - openPR
Trevena Inc. (TRVN) Quarterly 10-Q Report - Quartz
Chester County biopharm firm's latest layoffs impact its C-suite - The Business Journals
Trevena: Q3 Earnings Snapshot - San Francisco Chronicle
Trevena Faces Leadership Changes Amidst Financial Challenges - TipRanks
Trevena, Inc. Announces Board Changes - Marketscreener.com
Trevena Reports Third Quarter 2024 Results and Provides Business Update - StockTitan
CVS Health books $1.2 bn in restructuring charges with new CEO comments in focus - MSN
Why Viking Therapeutics Stock Plummeted After Soaring Today - MSN
23andMe appoints new board members as it works to stem the company's slide - MSN
Sequoia buys South Carolina RIA Family Asset Management - MSN
Opioids Market Size to be worth $15.03 Billion By 2031: The Insight Partners - finanznachrichten.de
23andMe appoints three new board members following abrupt resignations - MSN
Post Operative Pain Therapeutics Market to Witness Huge Growth - openPR
1.03%
大文字化:
|
ボリューム (24 時間):